1),8 human breast carcinoma (breast M25-SF),9 and mouse
lymphoma (P388D1).10 The structure of panaxytriol was
established as heptadec-1-ene-4,6-diyne-3,9,10-triol in 1989,11
and its absolute configuration was determined as 3R,9R,-
10R by circular dichroism (CD) analysis12 and confirmed
by total syntheses.13
Scheme 2
Our strategy for the synthesis of 1 is outlined in Scheme
1. We envisioned that the main carbon framework of the
Scheme 1
metric dihydroxylation,17 which selectively took place on the
disubstituted trans-double bond of 8 in 95% yield. The
resulting diol was then protected as its acetonide by treatment
with 2,2-dimethoxypropane (cat. PTSA, THF) to give 9 in
98% yield. In turn, 9 was converted to enyne 10 in 93%
overall yield through deacetylation (DIBAL-H, THF,
-78 °C), desilylation (TBAF, 10 mol % of AcOH, THF),
and O-allylation (NaH, allyl bromide, DMF). Addition of a
small amount of acetic acid to the reaction in the desilyation
minimizes undesired side reactions that lead to extensive
decomposition. For the etherification of the subsequent allylic
alcohol, we found that preformation of alkoxide increased
the extent of the undesired intramolecular addition of the
alkoxide to the nearby triple bond. This undesired byproduct
could be suppressed by adding sodium hydride to the mixture
of the alcohol and allyl bromide. The elongation of enyne
10 to diyne 4 was achieved in 92% yield employing the
Cadiot-Chodkiewicz reaction14 with silylated bromoalkyne
7 followed by desilylation (TBAF, 10 mol % AcOH, THF).
With the key substrate 4 in hand, we explored the tandem
ring-closing metathesis, metallotropic [1,3]-shift, and cross-
metathesis. When 4 was treated with Grubbs’ second-
generation catalyst18 (Grubbs II, 10 mol %, CH2Cl2, 40 °C)
in the presence of 2.0 equiv of alkene 3, the expected product
2 was obtained in 61% yield as a mixture of Z/E-isomers
(5:1)4a,19 together with ruthenium alkylidene 11′ (10%). The
isolated complex 11′ could be turned over to 2 upon
treatment with 3, which implies that this complex is a
catalytically viable intermediate in the catalytic cycle. The
yield of 11′ was increased up to 40% with stoichiometric
amount of Grubbs complex. We speculate that the stability
target molecule could arise from a tandem reaction sequence
of relay metathesis, metallotropic [1,3]-shift, and cross-
metathesis with enediyne 4 in the presence of an excess
amount of external alkene 3. The intricate array of multiply
unsaturated functional groups in 4 could be orchestrated by
the recently developed regioselective Alder ene reaction of
multiyne 514 with terminal alkene 6 followed by alkyne
homologation via the Cadiot-Chodkiewicz reaction15 with
bromoalkyne 7.
The eight-step synthesis of endiyne 4 was initiated by the
Ru-catalyzed Alder ene reaction of silylated diyne 5 and
1-decene to provide enyne 8 in 81% yield (Scheme 2).16 The
required (9R,10R)-diol was installed by the Sharpless asym-
(8) Saita, T.; Katano, M.; Matsunaga, H.; Kouno, I.; Fujito, H.; Mori,
M. Bio. Pharm. Bull. 1995, 18, 933.
(9) Matsunaga, H.; Saita, T.; Naguo, F.; Mori, M.; Katano, M. Cancer
Chemother. Pharmacol. 1995, 35, 291.
(10) Kim, J. Y.; Lee, K. W.; Kim, S. H.; Wee, J. J.; Kim, Y. S.; Lee, H.
J. Planta Med. 2002, 68, 119.
(11) Matsunaga, H.; Katano, M.; Yamamoto, H.; Mori, M.; Takata, K.
Chem. Pharm. Bull. 1989, 37, 1279.
(12) Kovayashi, M.; Mahmund, T.; Umezome, T.; Wang, W.; Murakami,
N.; Kitagawa, I. Tetrahedron 1997, 53, 15691.
(13) Total Syntheses: (a) Lu, W.; Zheng, G.; Cai, J. Synlett 1998, 737.
(b) Lu, W.; Zheng, G.; Gao, D.; Cai, J. Tetrahedron 1999, 55, 7157. (c)
Gurjar, M. K.; Kumar, V. S.; Rao, B. V. Tetrahedron 1999, 55, 12563. (d)
Yadav, J. S.; Maiti, A. Tetrahedron 2002, 58, 4955. (e) Mayer, S. F.;
Steinreiber, A.; Orru, R. V. A.; Faber, K. J. Org. Chem. 2002, 67, 9115.
(f) Yun, H.; Danishefsky, S. J. J. Org. Chem. 2003, 68, 4519. (g) Yun, H.;
Chou, T.-C.; Dong, H.; Tian, Y.; Li, Y.; Danishefsky, S. J. J. Org. Chem.
2005, 70, 10375.
(14) (a) Cho, E. J.; Lee, D. J. Am. Chem. Soc. 2007, 129, 6692. For
reviews on ruthenium-catalyzed Alder ene reaction, see: (b) Trost, B. M.;
Frederiksen, M. U.; Rudd, M. T. Angew. Chem., Int. Ed. 2005, 44, 6630.
(c) Trost, B. M.; Toste, F. D.; Pinkerton, A. B. Chem. ReV. 2001, 101,
2067.
(17) (a) Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.;
Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, Wang, K. Z.-M.; Xu,
D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768. (b) Kolb, H. C.;
VanNieuwenhze, M. S.; Sharpless, K. B. Chem. ReV. 1994, 94, 2483.
(18) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1,
953.
(19) Z-preference in cross-metathesis of enynes and acrylonitrile, see:
(a) Crowe, W. E.; Goldberg, D. R. J. Am. Chem. Soc. 1995, 117, 5162. (b)
Randl, S.; Gessler, S.; Wakamatsu, H.; Blechert, S. Synlett 2001, 430. (c)
Kang, B.; Kim, D.-h.; Do, Y.; Chang, S. Org. Lett. 2003, 5, 3041. (d) Kang,
B.; Lee, J. M.; Kwak, J.; Lee, Y. S.; Chang, S. J. Org. Chem. 2004, 69,
7661. (e) Love, J. A.; Morgan, J. P.; Trnka, T. M.; Grubbs, R. H. Angew.
Chem., Int. Ed. 2002, 41, 4035.
(15) (a) Marino, J. P.; Nguyen, H. N. J. Org. Chem. 2002, 67, 6841 and
Supporting Information. (b) Supporting Information of ref 3a for a slightly
modified reaction protocol.
(16) The transformation of 5 and 6 to 8 was reported in ref 13a.
258
Org. Lett., Vol. 10, No. 2, 2008